2023
26
October
2023
|
10:02
Europe/Amsterdam
Five-year-data from the BIOSTEMI trial confirmed the superiority of BIOTRONIK’s Orsiro® drug-eluting stent (DES) over Xience DES in patients with acute ST-segment elevation myocardial infarction (STEMI). Dr. Juan F. Iglesias, Geneva University Hospit...
Read more
